WHITNEY SCHLAFER: Open Payments
NPI 1780100214 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $175 |
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, NEFFY.
Industry payments across TN — which companies pay providers there.
